Lukas Biomedical Inc.
6814
Rank in Stocks
#26071
Founded in 2002 and headquartered in New Taipei, Taiwan, Lukas Biomedical Inc.... Founded in 2002 and headquartered in New Taipei, Taiwan, Lukas Biomedical Inc. primarily develops immune cell medical technologies. These innovations are utilized for regenerative medicine and as complementary treatments for cancer. The company's operations are segmented into four distinct areas: E-commerce, Medical Management Business, Cell Product, and Pharmaceutical Market. Furthermore, it diversifies its business by wholesaling and retailing cosmetics, alongside providing housing equipment rental services.
Share Price
$0.53347803
Last synced: 2026-11-10
Market Cap
$22.34M
Change (1 day)
-0.57%
Change (1 year)
-44.92%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Lukas Biomedical Inc. (6814)
Category
Healthcare
EPS for Lukas Biomedical Inc. (6814)
EPS as of June 2026 TTM: $-0.07
According to Lukas Biomedical Inc.'s latest financial reports, its current EPS (TTM) is $-0.07. At the end of 2025 the company had an EPS of $-0.07, equal to its 2024 EPS of $-0.07.
EPS history for Lukas Biomedical Inc. from 2017 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.07 | -3.00% |
| 2025 | $-0.07 | -10.34% |
| 2024 | $-0.07 | 73.86% |
| 2023 | $-0.04 | -5.23% |
| 2022 | $-0.04 | -18.67% |
| 2021 | $-0.05 | 374.56% |
| 2020 | $-0.01 | 70.15% |
| 2019 | $-0.01 | -74.91% |
| 2018 | $-0.03 | 49.16% |
| 2017 | $-0.02 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -23,163.33% |
US
|
|
| $-7.07 | 10,312.37% |
US
|
|
| $-5.29 | 7,690.87% |
AU
|
|
| $12.88 | -19,069.22% |
BE
|
|
| $21.56 | -31,852.58% |
NL
|
Questions about Lukas Biomedical Inc.'s earnings per share (EPS)
What is Lukas Biomedical Inc.'s earnings per share (EPS)?
Lukas Biomedical Inc.'s earnings per share (EPS) over the last twelve months is $-0.07, as of Jun 2026.
What was Lukas Biomedical Inc.'s earnings per share (EPS) in 2025?
In 2025, Lukas Biomedical Inc.'s earnings per share (EPS) was $-0.07, compared with $-0.07 in 2024.
How has Lukas Biomedical Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Lukas Biomedical Inc.'s earnings per share (EPS) was highest in 2020 ($-0.01) and lowest in 2025 ($-0.07).
How does Lukas Biomedical Inc.'s earnings per share (EPS) compare with similar companies?
Lukas Biomedical Inc.'s earnings per share (EPS) ($-0.07) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.